EARNINGS (LOSS) PER SHARE (Tables)

9 Months Ended

Sep. 30, 2020

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of basic and diluted net income attributable to common stockholders for both the three and nine months ended September 30, 2020 and 2019 (in thousands, except per share amounts):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2020			2019			2020			2019
Income attributable to common stockholders:
Net income	$	3,306		$	1,360		$	9,321		$	17,736
Dividends and accretion related to Series A Preferred Stock:
Cash dividends declared	(3,968)			(3,852)			(11,817)			(11,192)
PIK dividends declared	(1,190)			(1,156)			(3,545)			(3,358)
Accretion of discount	(1,587)			(1,511)			(4,702)			(4,319)
	(3,439)			(5,159)			(10,743)			(1,133)
Undistributed earnings allocated using the two-class method	—			—			—			—
Net loss attributable to common stockholders	$	(3,439)		$	(5,159)		$	(10,743)		$	(1,133)
	Three Months Ended September 30,						Nine Months Ended September 30,
	2020			2019			2020			2019
Weighted average number of shares of Common Stock outstanding	72,377			66,696			69,521			65,625
Additional shares outstanding if Series A Preferred Stock is converted to Common Stock	15,873			15,408			15,756			14,926
Total shares outstanding if Series A Preferred Stock is converted to Common Stock	88,250			82,104			85,277			80,551
Percentage of shares allocable to Series A Preferred Stock	18.0		%	18.8		%	18.5		%	18.5		%
Weighted average number of shares of Common Stock outstanding:
Basic	72,377			66,696			69,521			65,625
Effect of dilutive securities:
Warrants	—			—			—			—
Stock options	—			—			—			—
Restricted stock units	—			—			—			—
Diluted	72,377			66,696			69,521			65,625
Net loss per share attributable to common stockholders:
Basic and diluted	$	(0.05)		$	(0.08)		$	(0.15)		$	(0.02)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

As of September 30, 2020 and 2019, the following potential Common Stock equivalents were excluded from the computation of diluted net loss per share for the respective periods ending on these dates since the impact of inclusion was anti-dilutive (in thousands): 

	2020	2019
Series A Preferred Stock	15,873	15,408
Restricted stock units	3,096	2,887
Stock options	7,239	9,312
Warrants	18,128	18,128
Total	44,336	45,735